MADISON CRAZE: Open Payments
NPI 1467020347 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $156 |
| Novo Nordisk Inc | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $64 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| PFIZER INC. | 3 | $53 |
| Exact Sciences Corporation | 2 | $36 |
| Dexcom, Inc. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $15 |
Products named: CAPLYTA, Auvelity, ELIQUIS, FARXIGA, AIRSUPRA, BREZTRI, Rybelsus, Wegovy.
Industry payments across MI — which companies pay providers there.
